BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22205746)

  • 21. Gene loss and adaptation to hominids underlie the ancient origin of HIV-1.
    Etienne L; Hahn BH; Sharp PM; Matsen FA; Emerman M
    Cell Host Microbe; 2013 Jul; 14(1):85-92. PubMed ID: 23870316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights into the dual activity of SIVmac239 Vif against human and African green monkey APOBEC3G.
    Gaur R; Strebel K
    PLoS One; 2012; 7(11):e48850. PubMed ID: 23189135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of infectious SIVagm from human cells requires functional inactivation but not viral exclusion of human APOBEC3G.
    Takeuchi H; Kao S; Miyagi E; Khan MA; Buckler-White A; Plishka R; Strebel K
    J Biol Chem; 2005 Jan; 280(1):375-82. PubMed ID: 15528183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H.
    Binka M; Ooms M; Steward M; Simon V
    J Virol; 2012 Jan; 86(1):49-59. PubMed ID: 22013041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G.
    Schröfelbauer B; Senger T; Manning G; Landau NR
    J Virol; 2006 Jun; 80(12):5984-91. PubMed ID: 16731937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. APOBEC3F Constitutes a Barrier to Successful Cross-Species Transmission of Simian Immunodeficiency Virus SIVsmm to Humans.
    Nchioua R; Kmiec D; Gaba A; Stürzel CM; Follack T; Patrick S; Kirmaier A; Johnson WE; Hahn BH; Chelico L; Kirchhoff F
    J Virol; 2021 Aug; 95(17):e0080821. PubMed ID: 34132575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple lysines combined in HIV-1 Vif determines the responsiveness to CBF-β.
    Ai Y; Ma J
    Biochem Biophys Res Commun; 2015 Feb; 457(3):385-90. PubMed ID: 25582776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif.
    Pery E; Rajendran KS; Brazier AJ; Gabuzda D
    J Virol; 2009 Mar; 83(5):2374-81. PubMed ID: 19109396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential requirements for HIV-1 Vif-mediated APOBEC3G degradation and RUNX1-mediated transcription by core binding factor beta.
    Du J; Zhao K; Rui Y; Li P; Zhou X; Zhang W; Yu XF
    J Virol; 2013 Feb; 87(3):1906-11. PubMed ID: 23175372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G.
    Liu B; Yu X; Luo K; Yu Y; Yu XF
    J Virol; 2004 Feb; 78(4):2072-81. PubMed ID: 14747572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clues for two-step virion infectivity factor regulation by core binding factor beta.
    Ai Y; Ma J; Wang X
    J Gen Virol; 2017 May; 98(5):1113-1121. PubMed ID: 28516844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Convergence and divergence in the evolution of the APOBEC3G-Vif interaction reveal ancient origins of simian immunodeficiency viruses.
    Compton AA; Emerman M
    PLoS Pathog; 2013 Jan; 9(1):e1003135. PubMed ID: 23359341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction.
    Zhang W; Du J; Evans SL; Yu Y; Yu XF
    Nature; 2011 Dec; 481(7381):376-9. PubMed ID: 22190036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APOBEC3B Potently Restricts HIV-2 but Not HIV-1 in a Vif-Dependent Manner.
    Bandarra S; Miyagi E; Ribeiro AC; Gonçalves J; Strebel K; Barahona I
    J Virol; 2021 Nov; 95(23):e0117021. PubMed ID: 34523960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation.
    Ai Y; Zhu D; Wang C; Su C; Ma J; Ma J; Wang X
    J Virol; 2014 Oct; 88(20):12112-22. PubMed ID: 25122780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity.
    Dang Y; Wang X; York IA; Zheng YH
    J Virol; 2010 Sep; 84(17):8561-70. PubMed ID: 20592083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conserved and non-conserved features of HIV-1 and SIVagm Vif mediated suppression of APOBEC3 cytidine deaminases.
    Zhang W; Huang M; Wang T; Tan L; Tian C; Yu X; Kong W; Yu XF
    Cell Microbiol; 2008 Aug; 10(8):1662-75. PubMed ID: 18419775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CBFß and HIV Infection.
    Kim DY; Gross JD
    Adv Exp Med Biol; 2017; 962():415-431. PubMed ID: 28299671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNAJB8 facilitates autophagic-lysosomal degradation of viral Vif protein and restricts HIV-1 virion infectivity by rescuing APOBEC3G expression in host cells.
    Chand K; Barman MK; Ghosh P; Mitra D
    FASEB J; 2023 Mar; 37(3):e22793. PubMed ID: 36723955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dominant Negative Mutants of Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) Disrupt Core-Binding Factor Beta-Vif Interaction.
    Duan S; Yu X; Wang C; Meng L; Gai Y; Zhou Y; Gu T; Yu B; Wu J; Yu X
    J Virol; 2022 Sep; 96(17):e0055522. PubMed ID: 35950859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.